跳至主要内容
临床试验/NCT03580226
NCT03580226已完成不适用

Glycated Hemoglobin Targets and Glycemic Control: Link With Lipid, Uric Acid and Kidney Profile in Indonesian Diabetic Patients

Tarumanagara University0 个研究点目标入组 55 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
55
主要终点
Lipid Profile

研究概览

简要总结

This study aims to compare uric acid, lipid, and kidney profile along with management and complications of Indonesian diabetic patients with good and poor glycemic control based on glycated hemoglobin profile.

详细描述

Adult patients (≥ 18 years of age) with type 2 diabetes which are diagnosed under ICD-10 coding of E-11 were included in this study. The inclusion criteria are patients with primary diagnosis of E11and have visited the clinic at least twice with a complete record of glucose, uric acid, lipid and kidney profile. Participants were grouped into 2 groups - good and poor glycemic control based on their glycated hemoglobin (HbA1c) levels. Good glycemic control is defined according to the American Diabetes Association and the Indonesian Association of Endocrinologists (PERKENI) cut off of HbA1c < 7.0.

Data such as age, sex, ethnic, education, BMI, glucose, uric acid, lipid, and kidney profile as well as comorbidities and type of drug used were collected from the patients' medical records. Comorbid conditions were defined as either concomitant hypertension, dyslipidemia, chronic kidney disease, hyperuricemia, or combinations of them as diagnosed in the medical records. Diabetic complications of interest include macrovascular (heart disease, stroke), microvascular (nephropathy, retinopathy, neuropathy) and a combination of both as well as infection (urinary tract infection, pneumonia). These complications were also based on the medical records. Management modalities included were lifestyle modification, use of oral antidiabetic medications or insulin, or both.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Type 2 Diabetes
  • Must have visited the clinic at least twice, one before and one post-therapy

排除标准

  • Type 1 Diabetes, Gestational Diabetes and other secondary diabetes types
  • Unavailability of HbA1c results - pre and post-therapy
  • Incomplete records of glucose, uric acid, lipid and kidney profile, comorbidities and management.

结局指标

主要结局

Lipid Profile

时间窗: Through study completion, an average of 1 year

Low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol and triglyceride levels.

Kidney Profile

时间窗: Through study completion, an average of 1 year

Urea, Creatinine levels and Proteinuria

Uric Acid

时间窗: Through study completion, an average of 1 year

Uric Acid Levels

次要结局

未报告次要终点

研究者

发起方
Tarumanagara University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Anthony Paulo Sunjaya

Principal Investigator

Tarumanagara University

相似试验